<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03764319</url>
  </required_header>
  <id_info>
    <org_study_id>MUVienna ARDS-ECMO</org_study_id>
    <nct_id>NCT03764319</nct_id>
  </id_info>
  <brief_title>Low Frequency, Ultra-low Tidal Volume Ventilation in Patients With ARDS and VV-ECMO</brief_title>
  <official_title>Low Frequency, Ultra-low Tidal Volume Ventilation in Patients With Severe Acute Respiratory Distress Syndrome and Veno-venous Extracorporeal Membrane Oxygenation: a Prospective, Randomized, Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The acute respiratory distress syndrome (ARDS) is the most severe form of respiratory
      failure, presented in 10% of all intensive care patients and carrying a high mortality rate.
      Veno-venous extracorporeal membrane oxygenation (VV-ECMO) is a rescue treatment for patients
      with severe ARDS. Mechanical ventilator settings in patients with severe ARDS during VV-ECMO
      therapy are not clearly defined at the moment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is to assess the effect of a rigorous low breathing frequency and
      ultra-low tidal volume ventilation strategy on clinical outcome, compared to standard
      ventilator settings following the recent guidelines in patients with severe ARDS treated with
      VV-ECMO.

      The hypothesis is that a low breathing frequency and ultra-low tidal volume ventilation
      strategy is more protective for the ARDS challenged lung and reduces the duration of
      mechanical ventilation and so increases the ventilator free days in patients with severe ARDS
      treated with VV-ECMO.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 6, 2018</start_date>
  <completion_date type="Anticipated">May 6, 2020</completion_date>
  <primary_completion_date type="Anticipated">May 6, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Comparison of 2 groups</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ventilator free days</measure>
    <time_frame>Immediately after initiation of ECMO up to 28 days</time_frame>
    <description>Ventilator free days</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time from randomization to fulfillment of extubation criteria</measure>
    <time_frame>Immediately after initiation of ECMO up to 28 days</time_frame>
    <description>Time from randomization (initiation of ECMO) to fulfillment of the extubation criteria:
ARDS resolved
Temperature ≥ 36°C and ≤ 39°C
Low FiO2 (&lt; 0.5)
PEEP (&lt; 8 cmH2O) requirement
Able to initiate spontaneous breaths
Tidalvolume &gt; 5 mL/kg or &gt; 325 mL
Minute ventilation 5-6 L/min
PaO2/FiO2 &gt; 200 mmHg
pH ≥ 7.25
Ability to cough after deflating tube cuff
Respiratory rate 8-30/min
Hemodynamic stability</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total time of mechanical ventilation</measure>
    <time_frame>Start of mechanical ventilation up to 28 days</time_frame>
    <description>Total time of mechanical ventilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>28 day mortality</measure>
    <time_frame>Immediately after initiation of ECMO up to 28 days</time_frame>
    <description>Mortality from initiation of ECMO till day 28 after initiation of ECMO</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>One year mortality</measure>
    <time_frame>Immediately after initiation of ECMO up to one year</time_frame>
    <description>Mortality from initiation of ECMO till one year after initiation of ECMO</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of reintubation</measure>
    <time_frame>Immediately after initiation of ECMO up to 28 days</time_frame>
    <description>Incidence of reintubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of ICU stay</measure>
    <time_frame>Immediately after initiation of ECMO</time_frame>
    <description>Length of ICU stay</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>ARDS</condition>
  <condition>Acute Lung Injury</condition>
  <condition>Extracorporeal Membrane Oxygenation</condition>
  <condition>Respiratory Distress Syndrome</condition>
  <condition>Respiratory Tract Diseases</condition>
  <condition>Lung Diseases</condition>
  <condition>Lung Injury, Acute</condition>
  <arm_group>
    <arm_group_label>Intervention group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ultra-protective ventilator settings in patients with ARDS and VV-ECMO.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard ventilator settings in patients with ARDS and VV-ECMO.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Ultra-protective ventilator settings</intervention_name>
    <description>4-5 Breaths per minute; 14-16 cmH2O Positive endexpiratory pressure (PEEP) (adjust PEEP to 23 &lt; Plateau pressure &lt; 25 cmH2O); 23-25 cmH2O Plateau pressure (adjust to not exceed Tidal volume &gt; 4 mL/kg Predicted body weight (PBW)); &lt; 4mL/kg PBW Tidal volume; 1:5 Inspiration:Expiration (I:E)</description>
    <arm_group_label>Intervention group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard ventilator settings</intervention_name>
    <description>12-25 Breaths per minute; 8-12 cmH2O PEEP; max. 35 cmH2O Plateau pressure</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Moderate to severe ARDS - Partial pressure of oxygen/Fraction of inspired oxygen
             (PaO2/FiO2) &lt; 200 mmHg

          -  VV-ECMO &lt; 24 hours in situ

          -  Gender-matched

          -  Age-matched

        Exclusion Criteria:

          -  BMI &gt; 40

          -  Expected weaning of VV-ECMO &lt; 3 days (postoperative ECMO)

          -  Combustion

          -  Restrictive chest wall impairment

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roman Ullrich, Ao.Univ.Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anesthesia and Intensive Care</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Martina Loinger, Dr.med.univ.</last_name>
    <phone>+43 1 40400-41070</phone>
    <email>martina.loinger@meduniwien.ac.at</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Roman Ullrich, Ao.Univ.Prof.</last_name>
    <phone>+43 1 40400-41070</phone>
    <email>roman.ullrich@meduniwien.ac.at</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medical University of Vienna - Division of General Anaesthesia and Intensive Care Medicine</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martina Loinger, Dr.med.univ.</last_name>
      <phone>+43 1 40400-41070</phone>
      <email>martina.loinger@meduniwien.ac.at</email>
    </contact>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>November 29, 2018</study_first_submitted>
  <study_first_submitted_qc>December 4, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">December 5, 2018</study_first_posted>
  <last_update_submitted>February 19, 2020</last_update_submitted>
  <last_update_submitted_qc>February 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Martina Loinger</investigator_full_name>
    <investigator_title>Investigator</investigator_title>
  </responsible_party>
  <keyword>ARDS, ECMO, Ventilation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
    <mesh_term>Lung Injury</mesh_term>
    <mesh_term>Acute Lung Injury</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Respiratory Tract Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

